| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 12/12/2001 | CN1326444A Synthesis of intermediates useful in preparing tricyclic compounds |
| 12/12/2001 | CN1326443A Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors |
| 12/05/2001 | EP0845988B1 Novel fused isoquinolines as dopamine receptor ligands |
| 12/04/2001 | US6326153 Polynucleotide sequencing |
| 11/29/2001 | WO2001090077A1 Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses |
| 11/28/2001 | EP0850234B1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 11/28/2001 | EP0783503B1 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives |
| 11/27/2001 | US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative |
| 11/27/2001 | US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response. |
| 11/27/2001 | US6323194 Muscarinic agonists and antagonists |
| 11/22/2001 | WO2001087895A1 Synthetic process for the manufacture of an ecteinaschidin compound |
| 11/22/2001 | WO2001087894A1 Antitumoral analogs of et-743 |
| 11/22/2001 | WO2001087308A1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 11/22/2001 | CA2404704A1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 11/21/2001 | EP0641328B1 Bridged aza-bicyclic derivatives as substance p antagonists |
| 11/15/2001 | US20010041714 Serotonin-7 (5-HT7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole |
| 11/13/2001 | US6316639 Reacting dicarboxylic acids or anhydrides with a salt of hydroxyl-amine in solution selected from hydroxylamine sulfate, hydroxylamine nitrate, hydroxylamine acetate, hydroxylamine tetrafluoroborate, hydroxylamine phosphate |
| 11/13/2001 | US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 11/13/2001 | US6316404 Treatment of non-insulin-dependent diabetes mellitus using an rxr agonist alone or in combination with a ppar.gamma. agonist such as a thiazolidinedione compound. |
| 11/08/2001 | US20010039345 Novel compounds for generating chemiluminescence with a peroxidase |
| 11/07/2001 | EP1150971A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 11/07/2001 | CN1321158A Tricyclic delta 3-piperidines as pharmaceuticals |
| 11/06/2001 | US6313298 Spiro-indolines as Y5 receptor antagonists |
| 11/06/2001 | US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 11/06/2001 | US6313134 For therapy and prophylaxis of cardiac disease selected from the group consisting of cardiac arrhythmia, myocardial ischemia, myocardial infarction, sudden death caused by cardiac arrhythmiamyocardial infarction |
| 11/06/2001 | US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 11/01/2001 | WO2001081654A1 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems |
| 11/01/2001 | US20010036950 Potassium channel openers |
| 10/31/2001 | EP1149081A1 Aryloxy-poly(oxyalkylene) naphthalimide derivative colorants |
| 10/31/2001 | EP1149080A2 Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase |
| 10/31/2001 | CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof |
| 10/31/2001 | CN1319599A Process for preparing imidazolinone |
| 10/30/2001 | US6310208 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines |
| 10/30/2001 | US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 10/30/2001 | CA2216160C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 10/30/2001 | CA2029863C Compositions and methods for treating viral infections |
| 10/25/2001 | WO2001079204A1 Phenyl substituted 4-hydroxy tetrahydropyridone |
| 10/25/2001 | WO2001079199A1 Acetylene derivatives and herbicides containing the same |
| 10/25/2001 | WO2001079175A1 Synthesis of intermediates useful in preparing tricyclic compounds |
| 10/25/2001 | WO2001078713A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 10/25/2001 | WO2001027099A3 Bicyclic compounds composition and method for stabilizing the same |
| 10/25/2001 | US20010034341 Bactericides |
| 10/25/2001 | DE10019145A1 New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides |
| 10/24/2001 | EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 10/24/2001 | EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 10/24/2001 | EP1147087A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 10/24/2001 | CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 10/23/2001 | US6306881 Anti-inflammatory agents |
| 10/23/2001 | US6306870 N-cinnamoyl derivatives of beta-carboline |
| 10/23/2001 | US6306868 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives |
| 10/18/2001 | WO2001077115A1 Antitumoral ecteinascidin derivatives |
| 10/18/2001 | WO2001076602A1 Apomorphine derivatives and methods for their use |
| 10/18/2001 | WO2000071518A3 Heterocyclic analgesic compounds and their use |
| 10/18/2001 | CA2405419A1 Apomorphine derivatives and methods for their use |
| 10/17/2001 | EP1144381A2 Substituted benzo[de]isoquinoline-1,3-diones |
| 10/17/2001 | EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 10/17/2001 | EP0652871B1 Benzodiazepine derivatives |
| 10/17/2001 | CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation |
| 10/17/2001 | CN1318058A 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as CRTP inhibitors |
| 10/17/2001 | CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors |
| 10/17/2001 | CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers |
| 10/17/2001 | CN1073111C Process for preparation of 2,3-pyridinedicarboximides |
| 10/16/2001 | US6303785 Substituted n-cyclopropyltetrahydroisoquinolines |
| 10/16/2001 | US6303623 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |
| 10/11/2001 | WO2001074358A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 10/11/2001 | CA2403791A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 10/10/2001 | EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 10/10/2001 | EP1140871A1 Thrombin or factor xa inhibitors |
| 10/10/2001 | EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 10/10/2001 | EP1140094A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 10/10/2001 | EP0840731B1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists |
| 10/10/2001 | CN1317005A Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 10/10/2001 | CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound |
| 10/09/2001 | US6300340 Useful for therapy of cancer and solid tumors |
| 10/09/2001 | US6300338 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 10/09/2001 | US6300331 Naphthalimidobenzamide derivatives |
| 10/04/2001 | WO2001072713A1 Non-steroidal, tetracyclic compounds for estrogen-related treatments |
| 10/04/2001 | WO2001072707A2 Carbamate caspase inhibitors and uses thereof |
| 10/04/2001 | EP1138682A1 Novel water soluble c-ring analogues of 20 (s)-camptothecin |
| 10/04/2001 | EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 10/03/2001 | CN1315945A Nitrate salts of antihypertensive medicines |
| 10/03/2001 | CN1315177A Method for curing sexual dysfunction by specific blood plasma concentration apomorphine |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001017972A3 Novel herbicides |
| 09/27/2001 | CA2404002A1 Inhibitors of histone deacetylase |
| 09/26/2001 | EP1135373A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative |
| 09/26/2001 | EP1135132A2 Inhibitors of multidrug transporters |
| 09/26/2001 | EP0773943B1 Compounds useful as antiproliferative agents and garft inhibitors |
| 09/26/2001 | CN1314891A Synthesis of benzo (F) quinolinones |
| 09/26/2001 | CN1314347A Six kinds of isoquinoline alkaloid |
| 09/20/2001 | WO2001068588A1 POLYMER-IMMOBILIZED α-IMINOESTER |
| 09/20/2001 | WO2001068071A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 09/20/2001 | CA2401267A1 Use of natural compounds having antiangiogenic activity |
| 09/19/2001 | EP1133475A1 Substituted benzo de]isoquinoline-1,3-diones |
| 09/19/2001 | CN1313742A Treatment of female sexual dysfunction |
| 09/19/2001 | CN1071302C Process to prepare 5-formylvaleric acid |
| 09/18/2001 | US6291677 Compounds having activity as inhibitors of cytochrome P450RAI |
| 09/18/2001 | US6291477 Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia |
| 09/18/2001 | US6291474 Bicyclic amine derivatives |